Advertisement

Topics

Clock Is Ticking For Gemphire's Top CV Hope As Latest Trial Disappoints

09:12 EDT 8 Aug 2017 | SCRIP

Investors are worried time may run out for Gemphire's chances to capitalize on its oral inhibitor of cholesterol production that...

      

Related Stories

 

Original Article: Clock Is Ticking For Gemphire's Top CV Hope As Latest Trial Disappoints

NEXT ARTICLE

More From BioPortfolio on "Clock Is Ticking For Gemphire's Top CV Hope As Latest Trial Disappoints"

Quick Search
Advertisement